In addition to the effects of gain-of-function mutations in the TRPC6 gene, also elevated levels of wild-type TRPC6 protein in some acquired glomerular diseases, like membranous nephropathy and puromycin aminonucleoside-induced albuminuria, may lead to podocyte dysfunction [52]. The gene discussed is TRPC6; the disease is membranous glomerulonephritis.